Identification of Five Serum Protein Markers for Detection of Ovarian Cancer by Antibody Arrays | PLOS ONE
![Frontiers | Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry Frontiers | Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry](https://www.frontiersin.org/files/Articles/665595/fonc-11-665595-HTML/image_m/fonc-11-665595-g001.jpg)
Frontiers | Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry
![Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data - eClinicalMedicine Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data - eClinicalMedicine](https://www.thelancet.com/cms/attachment/a2e5d5d0-c5da-4842-a5f2-14ec3dc43ecc/gr1_lrg.jpg)
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data - eClinicalMedicine
Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging | PLOS ONE
![Profiling protein expression in circulating tumour cells using microfluidic western blotting | Nature Communications Profiling protein expression in circulating tumour cells using microfluidic western blotting | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncomms14622/MediaObjects/41467_2017_Article_BFncomms14622_Fig1_HTML.jpg)
Profiling protein expression in circulating tumour cells using microfluidic western blotting | Nature Communications
Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging | PLOS ONE
![IJMS | Free Full-Text | An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy IJMS | Free Full-Text | An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy](https://www.mdpi.com/ijms/ijms-20-04938/article_deploy/html/images/ijms-20-04938-g001-550.jpg)
IJMS | Free Full-Text | An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy
![Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332221012749-ga1.jpg)
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect
![Computational advances of tumor marker selection and sample classification in cancer proteomics - ScienceDirect Computational advances of tumor marker selection and sample classification in cancer proteomics - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S200103702030341X-gr3.jpg)
Computational advances of tumor marker selection and sample classification in cancer proteomics - ScienceDirect
![Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research](https://cdn.amegroups.cn/journals/pbpc/files/journals/5/articles/2729/public/2729-PB3-R1.png/w300)
Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research
![Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer | Clinical Proteomics | Full Text Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer | Clinical Proteomics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12014-022-09349-x/MediaObjects/12014_2022_9349_Fig2_HTML.png)
Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer | Clinical Proteomics | Full Text
![SciELO - Brasil - Biomarkers towards Ovarian Cancer Diagnostics: Present and Future Prospects Biomarkers towards Ovarian Cancer Diagnostics: Present and Future Prospects SciELO - Brasil - Biomarkers towards Ovarian Cancer Diagnostics: Present and Future Prospects Biomarkers towards Ovarian Cancer Diagnostics: Present and Future Prospects](https://minio.scielo.br/documentstore/1678-4324/cxCY4JSGVykggPThcYfMLQx/41429815e805f5b5fb2b209dbc321af51f5026e9.jpg)